SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-098627
Filing Date
2021-03-30
Accepted
2021-03-29 19:22:34
Documents
4
Period of Report
2021-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d165080d8k.htm 8-K 19499
2 EX-99.1 d165080dex991.htm EX-99.1 15654
3 GRAPHIC g165080g0329110713943.jpg GRAPHIC 1958
4 GRAPHIC g165080g0329110714114.jpg GRAPHIC 1743
  Complete submission text file 0001193125-21-098627.txt   41726
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39614 | Film No.: 21783136
SIC: 2836 Biological Products, (No Diagnostic Substances)